Home › Glioblastoma › California › Los Angeles
Studi clinici su Glioblastoma a Los Angeles, CA
24 studi su Glioblastoma cercano partecipanti presso sedi a Los Angeles e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
In reclutamentoFase 3
- Kaiser Permanente, Los Angeles
- UCLA, Los Angeles
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
In reclutamentoFase 3
- Keck Medicine of USC, Los Angeles
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
In reclutamentoFase 1/2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
In reclutamentoFase 2/3
- Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
In reclutamentoFase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
In reclutamentoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
In reclutamentoFase 1/2
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
In reclutamentoFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
In reclutamentoFase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
In reclutamentoFase 3
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
In reclutamentoFase 1/2
- UCLA Health Bowyer Oncology Center, Los Angeles
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
In reclutamentoFase 1
- University of California, Los Angeles (Data Collection Only), Los Angeles
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- University of California, Los Angeles, Los Angeles
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
In reclutamentoFase 2
- Cedars-Sinai Medical Center, Los Angeles
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
In reclutamentoFase 2
- Cedars-Sinai Medical Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
In reclutamentoFase 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
PH Sensitive MRI Based Resections of Glioblastoma
In reclutamentoFase 1
- Ronald Reagan Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
In reclutamento
- Oncology Institute for Hope and Innovation, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
In reclutamentoFase 1/2
- University of California Los Angeles, Los Angeles
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
In reclutamentoFase 3
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
In reclutamento
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
In reclutamentoFase 1/2
- University of California at Los Angeles, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
In reclutamentoFase 1/2
- Cedars Sinai Medical Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
In reclutamentoFase 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Studi su Glioblastoma in altre città
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Washington, DC15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Rochester, MN13 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Altri studi a Los Angeles
- Cancro del polmone non a piccole cellule87 studi
- Cancro (tutti i tipi)74 studi
- Cancro al seno73 studi
- Cancro alla prostata61 studi
- Cancro colorettale59 studi
- Cancro metastatico57 studi
- Cancro ovarico50 studi
- Cancro ai polmoni45 studi
- Carcinoma a cellule squamose della testa e del collo42 studi
- Cancro pancreatico35 studi
- Cancro dell'endometrio34 studi
- Melanoma34 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.